Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

[Overview of cardiovascular risk factors in diabetic patients: focus on hypoglycemia, dyslipidemia, body weight and cardiovascular disease].

Mannucci E, Dicembrini I.

G Ital Cardiol (Rome). 2013 Dec;14(12):4-8. doi: 10.1714/1375.15275. Italian.

PMID:
24362781
[PubMed - in process]
2.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
[PubMed - indexed for MEDLINE]
3.

The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.

Hoerger TJ, Ahmann AJ.

J Manag Care Pharm. 2008 Feb;14(1 Suppl C):S2-14; quiz 15-6. Review.

PMID:
18240890
[PubMed - indexed for MEDLINE]
Free Article
4.

Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Kones R.

Drug Des Devel Ther. 2011;5:325-80. doi: 10.2147/DDDT.S14934. Epub 2011 Jun 13. Review.

PMID:
21792295
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.

Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. French.

PMID:
19748369
[PubMed - indexed for MEDLINE]
6.

[Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].

Vanuzzo D, Pilotto L, Mirolo R, Pirelli S.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):6S-17S. Review. Italian.

PMID:
18773746
[PubMed - indexed for MEDLINE]
7.

Control to goal of cardiometabolic risk factors among Nigerians living with type 2 diabetes mellitus.

Okafor CI, Ofoegbu EN.

Niger J Clin Pract. 2012 Jan-Mar;15(1):15-8. doi: 10.4103/1119-3077.94089.

PMID:
22437081
[PubMed - indexed for MEDLINE]
Free Article
8.

[Treatment of diabetes in metabolic syndrome].

Pelikánova T.

Vnitr Lek. 2009 Jul-Aug;55(7-8):637-45. Review. Czech.

PMID:
19731868
[PubMed - indexed for MEDLINE]
9.

Improved glycemic control reduces the impact of weight gain on cardiovascular risk factors in type 1 diabetes. The Epidemiology of Diabetes Complications Study.

Williams KV, Erbey JR, Becker D, Orchard TJ.

Diabetes Care. 1999 Jul;22(7):1084-91.

PMID:
10388972
[PubMed - indexed for MEDLINE]
Free Article
10.

Dyslipidemia in type II diabetes. Implications for therapeutic intervention.

Stern MP, Haffner SM.

Diabetes Care. 1991 Dec;14(12):1144-59. Review.

PMID:
1773701
[PubMed - indexed for MEDLINE]
11.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
[PubMed - indexed for MEDLINE]
12.

[Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].

Ruetsch O, Viala A, Bardou H, Martin P, Vacheron MN.

Encephale. 2005 Jul-Aug;31(4 Pt 1):507-16. Review. French.

PMID:
16389718
[PubMed - indexed for MEDLINE]
13.

Cardiovascular implications of antihyperglycemic therapies for type 2 diabetes.

Ovalle F.

Clin Ther. 2011 Apr;33(4):393-407. doi: 10.1016/j.clinthera.2011.04.006. Review.

PMID:
21635987
[PubMed - indexed for MEDLINE]
14.

New perspectives in type 2 diabetes, cardiovascular risk, and treatment goals.

Wysham CH.

Postgrad Med. 2010 May;122(3):52-60. doi: 10.3810/pgm.2010.05.2142.

PMID:
20463414
[PubMed - indexed for MEDLINE]
15.

Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients.

Ji L, Hu D, Pan C, Weng J, Huo Y, Ma C, Mu Y, Hao C, Ji Q, Ran X, Su B, Zhuo H, Fox KA, Weber M, Zhang D; CCMR Advisory Board; CCMR-3B STUDY Investigators.

Am J Med. 2013 Oct;126(10):925.e11-22. doi: 10.1016/j.amjmed.2013.02.035. Epub 2013 Jun 27.

PMID:
23810406
[PubMed - indexed for MEDLINE]
16.

[Cardiovascular risk factors and prevention in women: similarities and differences].

Sclavo M.

Ital Heart J Suppl. 2001 Feb;2(2):125-41. Review. Italian.

PMID:
11255880
[PubMed - indexed for MEDLINE]
17.

Pharmacologic treatment of type 2 diabetic dyslipidemia.

Moon YS, Kashyap ML.

Pharmacotherapy. 2004 Dec;24(12):1692-713. Review.

PMID:
15585439
[PubMed - indexed for MEDLINE]
18.

[Hypoglycemic therapy in heart disease patients with type 2 diabetes mellitus].

Cosmi F, Cosmi D.

G Ital Cardiol (Rome). 2010 Jun;11(6):460-6. Review. Italian.

PMID:
20922871
[PubMed - indexed for MEDLINE]
19.

Type II diabetes mellitus.

Edelman SV.

Adv Intern Med. 1998;43:449-500. Review.

PMID:
9506190
[PubMed - indexed for MEDLINE]
20.

Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Gerstein HC, Riddle MC, Kendall DM, Cohen RM, Goland R, Feinglos MN, Kirk JK, Hamilton BP, Ismail-Beigi F, Feeney P; ACCORD Study Group.

Am J Cardiol. 2007 Jun 18;99(12A):34i-43i. Epub 2007 Apr 19.

PMID:
17599423
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk